We have clearly demonstrated corticotropin-releasing hormone (CRH) immunoreactive cell bodies and nerve fibers in the human hypothalamus by immunocytochemistry using free-floating sections instead of paraffin-embedded sections.
Corticotropin-releasing hormone (CRH) is a 41 amino acid peptide, which was originally isolated from the ovine hypothalamus (Vale et al., 1981) and has a potent stimulatory action in releasing adrenocorticotronic hormone (ACTH) and (Vale et al., 1981; Proulx-Ferland et al., 1982; Rivier et al., 1982; Turkelson et al., 1982) . Immunostaining of paraffin-embedded sections has already revealed that in the human hypothalamus CRH immunoreactivity exists in parvocellular cells of the paraventricular nucleus and nerve fibers in the paraventricular area, in the median eminence, around the pituitary stalk and in the posterior pituitary gland (Pelletier et al., 1983; Mouri et al., 1984 
Discussion
In the present study, by immunocytochemistry using free-floating sections, we could clearly demonstrate CRH immunoreactive cell bodies in the parvocellular paraventricular nucleus and nerve fibers from these cell bodies, which were larger in number and clearer than those revealed by immunocytochemistry with paraffinembedded sections (Pelletier et al., 1983; Mouri et al., 1984) .
Most of the CRH immunoreactive nerve fibers originating in the paraventricular nucleus pass under the fornix while some pass beyond the fornix and some through the fornix, then run downward toward the pituitary stalk. In the rat hypothalamus the pathway of CRH immunoreactive nerve fibers has already been reported in details (Merchenthaler et al., 1983) . As indicated here, the pathways of CRH immunoreactive nerve fibers in the human hypothalamus were similar to those in the rat hypothalamus.
Our findings corroborated the view that the CRH produced by the parvocellular cells of the paraventricular nucleus is transported through nerve fibers to the median eminence or around the portal capillaries in the pituitary stalk, where CRH is released into the portal vessels so that it regulates ACTH release from the anterior pituitary gland.
In the rat hypothalamus, colchicine administration into the lateral ventricle increases the CRH immunoreactivity in the perikarya of the parvocellular cells and adrenalectomy enhances CRH immunoreactivity in the perikarya and nerve fibers (Bloom et al., 1982; Bugnon et al., 1982; Merchenthaler et al., 1983 ; Swanson et al., 1983; Itoi et al., 1987) . But in the study of the human hypothalamus, such procedures to enhance immunoreactivity are immpossible.
In a previous study, immunoreactive CRH neurons were detectable in only 22% of the cases examined by employing paraffin sections of the human hypothalamus (Ohtani et al., 1987) . However, the positive cells were found in all cases examined in this study. Immunostaining in the present study was performed by using 40 pm-thick cryostat sections, which were incubated for a longer time (7 days) with a more diluted primary antibody (1: 10000) in order to enhance CRH immunostaining.
Thus, it is emphasized that human brain tissues obtained at autopsy within 3 postmortem hours may be usable for the immunocytochemical study of neuropeptides, and the free-floating method combined with the Vector ABC system with a heavy metal intensification allows us to demonstrate the CRH neuronal system more clearly than by immunocytochemistry with routine paraffin sections.
